Relapsed Follicular Lymphoma Randomised Trial Against Standard ChemoTherapy

NCT05848765 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

284

Enrollment

OTHER

Sponsor class

Conditions

Relapsed Follicular Lymphoma
Refractory Follicular Lymphoma

Interventions

DRUG: Epcoritamab
DRUG: Lenalidomide
DRUG: Rituximab
DRUG: Obinutuzumab
DRUG: Bendamustine
DRUG: Vincristine
DRUG: Doxorubicin
DRUG: Cyclophosphamide
DRUG: Prednisone
DRUG: Investigation agent 2
DRUG: Investigation agent 3

Sponsor

University of Birmingham

Collaborators

[object Object]
[object Object]